Jaykay Enterprises Other Announcement
Jaykay Enterprises Ltd has filed its quarterly shareholding pattern with the exchange. The disclosure provides details on promoter and public shareholding as per regulatory requirements.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Jaykay Enterprises Ltd has filed its quarterly shareholding pattern with the exchange. The disclosure provides details on promoter and public shareholding as per regulatory requirements.
Jaykay Enterprises issued a letter to shareholders informing them of web links to access the FY 2025-26 Annual Report and 80th AGM Notice.
Jaykay Enterprises Limited filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its previous Rights Issue.
Jaykay Enterprises subsidiary JK Digital received ISO 14001 and ISO 45001 certifications for medical implant manufacturing. This validates the company's focus on additive manufacturing and international quality standards.
Jaykay Enterprises Limited filed its Annual Secretarial Compliance Report for the financial year 2026. The report confirmed full regulatory compliance with no deviations or penalties.
Jaykay Enterprises Limited's subsidiary, Neumesh Labs Private Limited, received an investigation notice from the Ministry of Corporate Affairs seeking information for examination. The company stated that no specific violations were mentioned and no immediate material financial impact has been identified. Neumesh Labs is cooperating with the authorities for document submission.
Jaykay Enterprises Ltd's subsidiary, JK Digital & Advance Systems, received ISO 13485:2016 and ISO 9001:2015 certifications for manufacturing medical implants using additive manufacturing. This milestone enables end-to-end manufacturing solutions for sterile revision surgery implants. The certifications cover hip, spinal, and patient-specific implants.